학술논문

Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
Document Type
article
Source
Clinical Gastroenterology and Hepatology. 19(11)
Subject
Clinical Research
Brain Disorders
Digestive Diseases
Prevention
Biomedical Imaging
Liver Disease
Hepatitis
Clinical Trials and Supportive Activities
Adult
Biomarkers
Female
Humans
Liver
Magnetic Resonance Imaging
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Protons
Steatohepatitis
Clinical Trial
Steatosis
Liver Biopsy
Histology
Clinical Sciences
Gastroenterology & Hepatology
Language
Abstract
Background & aimsMagnetic resonance imaging proton density fat fraction (MRI-PDFF) offers promise as a non-invasive biomarker of treatment response in early-phase nonalcoholic steatohepatitis (NASH) trials. We performed a systematic review to quantify the association between a ≥ 30% reduction in MRI-PDFF and histologic response in NASH.MethodsWe searched the Cochrane Library, Embase, Medline and trial registries through May 2020 for early-phase clinical trials that incorporated MRI-PDFF and examined histologic response following intervention in adults with NASH. Subjects were classified as MRI-PDFF responders (relative decline in liver fat ≥30%) or non-responders (relative decline in liver fat